McKesson Corp, a leading healthcare provider and distributor, is poised for growth with analysts predicting a significant increase in earnings per share and a strong foundation for continued success.
McKesson’s stock price has been highly volatile, with a price-to-earnings ratio of 27.54 and a negative price-to-book ratio of -24.2074, raising concerns about the company’s valuation and potential for a market correction.